FGFR2/CD332 Antibody, Unconjugated, Monoclonal
Catalog Number:
BYT-ORB1806350
- Images (6)
| Article Name: | FGFR2/CD332 Antibody, Unconjugated, Monoclonal |
| Biozol Catalog Number: | BYT-ORB1806350 |
| Supplier Catalog Number: | orb1806350 |
| Alternative Catalog Number: | BYT-ORB1806350-1,BYT-ORB1806350-100 |
| Manufacturer: | Biorbyt |
| Category: | Antikörper |
| Application: | ELISA, FA, FACS, In vivo |
| Species Reactivity: | Human |
| Conjugation: | Unconjugated |
| Anti-FGFR2 / CD332 Reference Antibody is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.24 kDa. |
| Clonality: | Monoclonal |
| Concentration: | Batch dependent |
| Molecular Weight: | 144 kDa |
| UniProt: | P21802 |
| Buffer: | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Purity: | >95% |
| Target: | FGFR2 / CD332 |
|
|
Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%. |
|
|
The purity of Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab)is more than 100% ,determined by SEC-HPLC. |
|
|
SNU-16 cells were stained with Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC763=0.5368 µg/mL. |
|
|
Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab) induced ADCC activity was evaluated using Human FGFR2 HEK293 Reporter Cell.The max induction fold was approximately 25. |
|
|
Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab) -ADCC luciferase Assay on KATOIII cells. The maximum suppression factor is approximately 14. |
|
|
Bemarituzumab inhibited the tumor growth of SNU-16 on Balb/c nude mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 29.7% at 2 mpk at D62. |
Product Guarantee and Expert Support
